➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
Boehringer Ingelheim
Johnson and Johnson
Merck
Express Scripts

Last Updated: January 24, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Torcetrapib

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Torcetrapib?

Torcetrapib is an investigational drug.

There have been 17 clinical trials for Torcetrapib. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2009.

The most common disease conditions in clinical trials are Hyperlipidemias, Hypercholesterolemia, and Hyperlipoproteinemia Type II. The leading clinical trial sponsors are Pfizer, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), and Dr. Reddy's Laboratories Limited.

Recent Clinical Trials for Torcetrapib
TitleSponsorPhase
A Proof of Concept Study to Determine the Local Delivery and Efficacy of NanocortAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Phase 1/Phase 2
A Safety and Efficacy Study of DRL-17822, a Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Patients With Abnormal Cholesterol LevelsPharmaNetPhase 2
A Safety and Efficacy Study of DRL-17822, a Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Patients With Abnormal Cholesterol LevelsDr. Reddy's Laboratories LimitedPhase 2

See all Torcetrapib clinical trials

Clinical Trial Summary for Torcetrapib

Top disease conditions for Torcetrapib
Top clinical trial sponsors for Torcetrapib

See all Torcetrapib clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
Boehringer Ingelheim
Johnson and Johnson
Merck
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.